Test Price
2,800 AED✅ Home Collection Available
CYLD Gene (Multiple Familial Trichoepithelioma Type 1) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic post-test genetic counselling and result interpretation by DHA-licensed specialists.
- Insurance: Direct billing verification via WhatsApp +971 54 548 731.
Test Overview & Methodology
The CYLD gene test identifies pathogenic mutations linked to multiple familial trichoepithelioma type 1, a hereditary skin tumor syndrome. Early diagnosis enables proactive dermatological surveillance and genetic counseling for family members.
| Feature | Our NGS Test | Closest Alternative (Sanger) |
|---|---|---|
| Precision | 99.9% sensitivity | ~95% for point mutations |
| Method | NGS with CNV analysis | Sanger sequencing |
| Turnaround | 3–4 weeks | 6–8 weeks |
| Gene Coverage | Full coding exons ±10 bp splice sites | Selected exons only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics | DHA License: 9294403): "The CYLD gene test provides essential insights for managing hereditary skin tumor syndromes. Results should be interpreted within the full clinical context, and a negative result does not eliminate the need for continued surveillance. Always discuss findings with a genetics specialist."
Important Advisory
Do not discontinue any prescribed medication or treatment without consulting your physician. This test does not replace ongoing dermatological care.
Exclusion Criteria & Safety Precautions
- Inability to provide informed genetic consent (patient must be ≥18 years or have legal guardian).
- Minors without parental consent in accordance with Federal Law No. 2 of 2019.
- No suggestive personal or family history of multiple trichoepithelioma or cylindromatosis.
- Hemolyzed or degraded sample – resampling required.
- Mandatory: A pre-test genetic counseling session and a three-generation pedigree chart must be completed before sample collection.
- Emergency Red Flags: If any skin lesion becomes rapidly enlarging, ulcerated, or bleeding, seek urgent dermatological evaluation immediately.
Patient FAQ & Clinical Guidance
1. What is the purpose of this CYLD gene test?
Our test detects CYLD mutations with 99.9% sensitivity for definitive diagnosis of multiple familial trichoepithelioma. It clarifies hereditary risk, guides skin surveillance schedules, and supports family planning decisions. A genetic counsellor will explain the implications before testing.
2. How is the sample collected and what is the turnaround time?
A certified phlebotomist collects blood or DNA in your home via our VIP mobile phlebotomy service, and results are reported within 3 to 4 weeks. The sample can be whole blood, extracted DNA, or a dried blood spot on an FTA card. All samples are transported under ISO cold‑chain protocols to ensure stability.
3. Does insurance cover this test and how do I proceed?
Insurance may cover genetic testing when medically necessary; send your policy details via WhatsApp for verification. Our team will confirm pre‑authorization and direct billing options, and guide you through the required documentation, including the mandatory pedigree chart.
UAE Regulatory & Data Privacy Adherence
This test fully adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All processing occurs in an ISO 9001:2015 certified laboratory. DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | CYLD Gene (Multiple Familial Trichoepithelioma Type 1) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Whole Blood (Peripheral), Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next Generation Sequencing (NGS) with CNV analysis |
| ICD-10-CM Code | Q82.8, Z15.09, Z84.81 |
| LOINC Code | 93792-9 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians